SGCB and pulmonary arterial hypertension: It has been shown that direct pharmacological stimulation of sGC by BAY 41–2272 results in pulmonary vasodilation in lambs [7] and reverses hemodynamic and structural changes associated with monocrotaline- and hypoxia-induced pulmonary hypertension (PH) in rats and mice [8].